Announcements

Updates on campus events, policies, construction and more.

close  

Information for Our Community

Whether you are part of our community or are interested in joining us, we welcome you to Washington University School of Medicine.

close  


Visit the News Hub

Bacteria’s appetite may be key to cleaning up antibiotic contamination

Antibiotics in environment contribute to drug resistance

by Tamara BhandariApril 30, 2018

Michael Worful

Antibiotics can be lifesaving for people suffering from serious bacterial infections such as pneumonia and meningitis. The drugs are lethal to bacteria — but some bacteria fight back by developing resistance to antibiotics, and a few not only resist the onslaught, but turn the lethal drugs into food.

Scientists have understood little about how bacteria manage to consume antibiotics safely, but new research from Washington University School of Medicine in St. Louis illuminates key steps in the process.

The findings, published April 30 in Nature Chemical Biology, could lead to new ways to eliminate antibiotics from land and water, the researchers said. Environmental antibiotic contamination promotes drug resistance and undermines our ability to treat bacterial infections.

“Ten years ago we stumbled onto the fact that bacteria can eat antibiotics, and everyone was shocked by it,” said senior author Gautam Dantas, PhD, an associate professor of pathology and immunology, of molecular microbiology, and of biomedical engineering. “But now it’s beginning to make sense. It’s just carbon, and wherever there’s carbon, somebody will figure out how to eat it. Now that we understand how these bacteria do it, we can start thinking of ways to use this ability to get rid of antibiotics where they are causing harm.”

Drug resistance is a serious and worsening problem that threatens to set medical care back to a time when antibiotics were not yet discovered and infectious disease was the number one cause of death worldwide.

Modern industrial and agricultural practices are hastening the rise of antibiotic resistance by saturating the environment with active drugs. In India and China, which together produce the vast majority of the world’s antibiotics, pharmaceutical factories sometimes dump antibiotic-laden waste into local waterways. In the United States, some farmers add antibiotics to their animal feed to help their livestock grow, which produces waste loaded with the drugs.

Bacteria easily share genetic material. So when antibiotics infiltrate the water and soil, resident bacteria respond by spreading antibiotic resistance genes through the community.

Dantas, postdoctoral researcher and first author Terence Crofts, PhD, and colleagues wanted to understand how some environmental bacteria not only withstand antibiotics, but feed on them. They studied four distantly related species of soil bacteria that all flourish on a diet of penicillin alone. Penicillin was the first antibiotic discovered, but it has fallen out of favor because of resistance. Other members of the penicillin family such as amoxicillin and ampicillin are still effective and widely prescribed to treat bacterial infections.

The researchers found three distinct sets of genes that became active while the bacteria ate penicillin but inactive while the bacteria ate sugar. The three sets of genes correspond to three steps bacteria take to transform a lethal compound into a meal.

All of the bacteria start by neutralizing the dangerous part of the antibiotic. Once the toxin is disarmed, they snip off a tasty portion and eat it.

Understanding the steps involved in converting an antibiotic into food could help researchers bioengineer bacteria to clean up soil and waterways contaminated with drugs and thereby slow the spread of drug resistance. The soil bacteria that naturally eat antibiotics are finicky and difficult to work with. But a more tractable species such as E. coli potentially could be engineered to feed on antibiotics in polluted land or water.

Crofts and Dantas showed they could give E. coli the ability to survive and thrive on penicillin. The bacterium normally requires sugar, but with some genetic modification and the addition of a key protein, it flourished on a sugar-free diet of penicillin.

“With some smart engineering, we may be able to modify bacteria to break down antibiotics in the environment,” Crofts said.

Any such bioengineering project would have to include a plan to speed up the antibiotic-eating process. The way soil bacteria naturally remove antibiotics from the environment is effective but slow. They couldn’t possibly handle the amounts of antibiotics near pharmaceutical factories and in sewage facilities.

“You couldn’t just douse a field with these soil bacteria today and expect them to clean everything up,” Dantas said. “But now we know how they do it. It is much easier to improve on something that you already have than to try to design a system from scratch.”

Crofts TS, Wang B, Spivak A, Gianoulis TA, Forsberg KJ, Gibson MK, Johnsky LA, Broomall SM, Rosenzweig CN, Skowronski EW, Gibbons HS, Sommer MOA, Dantas G. Shared strategies for β-lactam catabolism in the soil microbiome. Nature Chemical Biology. April 30, 2018.

This work is supported by the National Institutes of Health (NIH), NIH Director’s New Innovator Award; National Institute of Diabetes and Digestive and Kidney Diseases, grant numbers DP2DK098089 and T32 DK077653; National Institute of General Medical Sciences, grant numbers R01GM099538 and T32 GM007067; National Institute of Allergy and Infectious Diseases, grant number R01AI123394; National Institute of Child Health and Development, grant number T32 HD049305; National Human Genome Research Institute, grant number T32 HG000045; Edward Mallinckrodt, Jr. Foundation; National Science Foundation, award numbers DGE-1143954 and DGE-1143954; and Washington University in St. Louis, Mr. and Mrs. Spencer T. Olin Fellowship.

Washington University School of Medicine’s 1,300 faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children’s hospitals. The School of Medicine is a leader in medical research, teaching and patient care, ranking among the top 10 medical schools in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children’s hospitals, the School of Medicine is linked to BJC HealthCare.

Tamara covers infectious diseases, molecular microbiology, neurology, neuroscience, surgery, the Institute for Informatics, the Division of Physician-Scientists and the MSTP program. She holds a double bachelor's degree in molecular biophysics & biochemistry and in sociology from Yale University, a master's in public health from the University of California, Berkeley, and a PhD in biomedical science from the University of California, San Diego. She joined WashU Medicine Marketing & Communications in 2016. She has received three Robert G. Fenley writing awards from the American Association of Medical Colleges: a bronze in 2020 for "Mind’s quality control center found in long-ignored brain area," a silver in 2022 for "Mice with hallucination-like behaviors reveal insight into psychotic illness," and a bronze in 2023 for "Race of people given Alzheimer’s blood tests may affect interpretation of results." Since January of 2024, Tamara has been writing under the name Tamara Schneider.